The synthetic biology leader set a new watermark for quarterly revenue in the second quarter and made a major acquisition. Here’s what investors need to know.
The synthetic biology leader set a new watermark for quarterly revenue in the second quarter and made a major acquisition. Here’s what investors need to know.